Organometallics
Article
1
residual protonated solvent as an internal standard ( H: CDCl 7.26
tube, 3 mL of dry DMF was added, and the reaction mixture was
heated to 90 °C for 24 h. During the reaction, a white colored solid
started precipitating which was isolated by filtration, washed with
diethyl ether (2 × 10 mL), and dried in vacuo to get [L1-H ]Br as an
3
1
3
1
ppm, CD CN 1.94 ppm, and DMSO-d 2.50 ppm; C{ H}: CDCl
3
6
3
7
7.1 ppm, CD CN 1.32 and 118.26 ppm, and DMSO-d 39.52 ppm).
3
6
Coupling constants are expressed in hertz (Hz). High resolution ESI-
mass spectra were recorded with an Agilent 6545A Q-TOF. EtBr,
imidazole, iron powder, CuO, NH Cl, Ag O, Cs CO , and NH PF
2
2
1
off-white hygroscopic solid. Yield: 1.4 g (3.28 mmol, 87%). H NMR
(400 MHz, CD CN): δ 10.58 (s, 1H), 10.08 (s, 1H), 9.03 (s, 1H),
4
2
2
3
4
6
3
were purchased from commercial sources and used as received
8.30 (s, 1H), 8.14 (bs, 2H), 7.74 (s, 1H), 4.73 (q, J = 7.5 Hz, 2H),
4.58 (q, J = 7.5 Hz, 2H), 4.40 (q, J = 7.5 Hz, 2H), 1.69−1.59 (m, 9H)
without further purification.
2
0a
13
1
Synthesis of 4/5-Bromobenzimidazole (2).
A 100 mL
ppm. C{ H} NMR (126 MHz DMSO-d ): δ 144.2 (N-CH-N),
6
Schlenk tube was charged with 4-bromo-2-nitroaniline (1.0 g, 4.6
135.9 (N-CH-N), 132.9, 131.3, 131.1, 123.2, 121.6, 120.4, 115.5,
108.0, 44.9, 42.7, 42.5 (N-CH ), 14.8, 14.3, 14.1 (N-CH CH ) ppm.
MS (ESI, positive ions): m/z 453.0089 (calculated for [M + Na]
mmol), Fe powder (3.09 g, 55.2 mmol), and NH Cl (2.95 g, 55.2
2
2
3
4
+
mmol). Then isopropanol (40 mL) and conc. formic acid (18 mL)
were added to it, and the reaction mixture was refluxed for 12 h at 80
453.0083).
°C. After the completion, the reaction mixture was cooled and the
Synthesis of [(L1-H)Ir(Cp*)Br
2
]Br (6). A mixture of [Ir(Cp*)-
]Br (100 mg, 0.232 mmol),
greenish solution was filtered through a Buchner funnel. The filtrate
was then concentrated by rotary evaporation, and the obtained
residue was dissolved in 15 mL of DCM followed by washing with
saturated sodium bicarbonate solution to neutralize the unreacted
formic acid. After separation, the organic phase was dried over
Cl
]
2
2
(93 mg, 0.116 mmol), [L1-H
2
2
NaOAc (21.0 mg, 0.255 mmol), and an excess of KBr in acetonitrile
(5 mL) was stirred at 85 °C for 3 h in a pressure tube. After the
reaction, the obtained solution was filtered through a pad of Celite
and all the volatiles from the filtrate were removed in high vacuo. The
residue was further purified by silica-gel column chromatography
(DCM:MeOH = 95:5 v/v) to provide compound 6 as an orange
anhydrous MgSO and concentrated in vacuo to provide a yellow
4
solid which was then purified via silica-gel column chromatography by
1
using DCM:MeOH (98:2 v/v) as eluent. Yield: 0.770 g (3.91 mmol,
hygroscopic solid. Yield: 130 mg (0.155 mmol, 67%). H NMR (500
1
8
5%). H NMR (400 MHz, CDCl ): δ 8.07 (s, 1H, benzimidazole N-
MHz, CD CN): δ 9.74 (t, J = 1.8 Hz, 1H), 8.04 (d, J = 2.1 Hz, 1H),
3
3
CH-N proton), 7.82 (s, 1H), 7.53 (d, J = 8.6 Hz, 1H), 7.41 (dd, J =
7.92 (t, J = 1.8 Hz, 1H), 7.77 (d, J = 8.7 Hz, 1H), 7.67 (t, J = 1.8 Hz,
1H), 7.61 (dd, J = 8.7, 2.1 Hz, 1H), 5.12−5.07 (m, 2H), 4.37 (m,
1
3
1
8
1
.6, 1.7 Hz, 1H) ppm. C{ H} NMR (101 MHz, CDCl ) δ 141.7,
3
1
3
1
39.1, 136.8, 126.4, 118.6, 116.8, 116.2 ppm. MS (ESI, positive ions):
4H), 1.60−1.54 (m, 25H) ppm. C{ H} NMR (126 MHz, CD CN):
3
+
III
m/z 196.9711 (calculated for [M + H] 196.9714).
δ 173.1 (Ir -CNHC), 136.5, 136.4, 136.3, 131.3, 123.7, 123.0, 113.5,
107.4, 91.5 (Cp*), 46.3, 46.1, 46.0, 17.0, 16.9, 15.5, 9.5 (Cp*) ppm.
Synthesis of 4/5-Bromo-1-ethyl-1H-benzimidazole (3). In a
round-bottom flask, 4/5-bromobenzimidazole (0.5 g, 2.53 mmol),
+
MS (ESI, positive ions): 757.0918 (calculated for [M − Br]
+
2
5% NaOH aq. soln. (2 mL), and 20 mL of acetonitrile were taken.
757.0910), 675.1677 (calculated for [M − 2Br − H] 675.1668),
+
2
Then ethyl bromide (0.226 mL, 3.03 mmol) was added dropwise to
this suspension, which was stirred for 24 h at room temperature. After
the reaction time, all the volatiles were removed by a rotary
evaporator, diluted with 20 mL of DCM, and washed with water.
After separation, the organic phases were combined and dried over
338.0898 (calculated for [M − 2Br] 338.0873).
Synthesis of Complex (7). A mixture of 6 (50 mg, 0.06 mmol),
Pd(OAc) (13.5 mg, 0.06 mmol), NaOAc (5 mg, 0.06 mmol), and an
2
excess of KBr in acetonitrile (2 mL) and pyridine (3 mL) solvent
mixture was heated at 80 °C overnight in a Schlenk tube. After the
completion of the reaction, the resultant solution was filtered through
a pad of Celite and all the volatiles were removed in high vacuo. The
obtained residue was further purified by silica-gel column chromatog-
raphy (DCM:MeOH = 95:5 v/v), followed by crystallization, to yield
MgSO , and removal of all the volatiles under reduced pressure
4
yielded a mixture of regioisomers of (4/5)-bromo-1-ethyl-1H-
benzimidazole as a yellow viscous liquid. The obtained viscous liquid
was further purified via silica-gel column chromatography
1
the compound 7 as a yellow solid. Yield: 34.0 mg (0.031 mmol, 52%).
(
DCM:MeOH = 99:1 v/v). Yield: 0.427 g (1.89 mmol, 75%). H
1
NMR (500 MHz, CDCl ) δ 7.94 (d, J = 1.7 Hz, 1H), 7.89 (m, 2H),
H NMR (400 MHz, CDCl ) δ 8.82−8.81 (m, 2H), 8.59 (s, 1H),
3
3
7
2
6
1
1
.66 (d, J = 8.6 Hz, 1H), 7.56 (d, J = 1.7 Hz, 1H), 7.41−7.36 (m,
7.71−7.67 (m, 1H), 7.58−7.52 (m, 2H), 7.28 (s, 1H), 7.26−7.21 (m,
2H), 7.17 (d, 1H), 5.24−5.06 (m, 2H), 4.85−4.70 (m, 2H), 4.34−
H), 7.27 (d, J = 8.6 Hz, 1H), 4.22−4.16 (m, 4H), 1.55−1.51 (m,
H) ppm. 13C{ H} NMR (101 MHz, CDCl ): δ 145.2, 143.3, 143.0,
1
13
1
4.26 (m, 2H), 1.73−166 (24H) ppm. C{ H} NMR (126 MHz,
3
III
II
42.9, 134.7, 132.6, 125.9, 125.4, 123.2, 121.7, 116.2, 115.2, 112.7,
CDCl ): δ 170.7 (Ir -CNHC), 154.5 (Pd -CNHC), 152.6, 149.5, 138.0,
3
10.8, 40.1, 40.0, 15.2 (broad singlet) ppm. MS (ESI, positive ions):
135.1, 135.07, 135.0, 125.2, 124.7, 123.9, 121.8, 120.9, 111.3, 110.6,
+
m/z 225.0029 (calculated for [M + H] 225.0027).
90.3 (Cp*), 46.8, 45.8, 45.6, 16.7, 16.6, 15.6, 9.6 (Cp*) ppm. MS
+
Synthesis of 1-Ethyl-5/6-(1H-imidazol-1-yl)-1H-benzimida-
zole (4). N-Ethyl-4/5-bromobenzimidazole (0.774 g, 3.43 mmol),
imidazole (0.9 g, 13.76 mmol), K CO (1.9 g, 13.76 mmol), and CuO
(ESI, positive ions): 1021.9417 (calculated for [M − Br]
+
1021.9474), 942.9023 (calculated for [M-Br-pyridine] 942.9051),
+2
860.9759 (calculated for [M − 2Br − H − pyridine] 860.9800).
2
3
(0.068 g, 0.858 mmol) were dissolved in dry DMSO (10 mL). Then
Synthesis of Complex (8). A mixture of 6 (50 mg, 0.06 mmol)
the reaction mixture was stirred at 150 °C for 48 h, after which the
reaction mixture was partitioned between water and DCM. The
organic layer was separated, and the aqueous layer was extracted with
DCM. The combined organic phases were washed with brine and
and Ag O (8.5 mg, 0.035 mmol) in 5 mL of DCM was stirred
overnight at room temperature in a Schlenk tube under the exclusion
2
of light. Then [Au(SMe )Cl] (19.5 mg, 0.065 mmol) was added to
2
the reaction mixture, which was again stirred for an additional 12 h.
After the completion of reaction, the resultant solution was filtered
through a pad of Celite and all the volatiles from the filtrate were
removed in high vacuo. The obtained product was washed with
diethyl ether (2 × 5 mL) and dried under high vacuum to yield a
yellow-orange solid which was crystallized from a chloroform solution
dried over MgSO , and all solvents were removed in vacuo. The crude
4
product was loaded on a silica-gel column and eluted with
DCM:MeOH (95:5 v/v) to provide compound 4 (as a mixture of
regioisomers) as a light brownish liquid. Yield: 0.58 g (2.75 mmol,
1
8
0%). H NMR (500 MHz, CDCl ): δ 8.02 (d, J = 4.9 Hz, 2H), 7.89
3
(
d, J = 8.4 Hz, 3H), 7.82 (d, J = 1.7 Hz, 1H), 7.50 (d, J = 8.4 Hz, 1H),
via slow diffusion of Et
compound 8. The presence of chloride instead of bromide at the
iridium center in 8 possibly happened either during the Ag O reaction
in DCM or during the crystallization from chloroform, which is not
2
O at ambient temperature to yield the
7
3
7
1
1
1
.41 (d, J = 1.7 Hz, 1H), 7.36 (d, J = 1.9 Hz, 1H), 7.35−7.31 (m,
H), 7.23 (d, J = 4.6 Hz, 2H), 4.29 (p, J = 7.3 Hz, 4H), 1.59 (td, J =
2
1
3
1
.3, 0.9 Hz, 6H) ppm. C{ H} NMR (126 MHz, CDCl ) δ 144.5,
3
20b
1
44.2, 143.9, 143.3, 136.4, 134.1, 133.2, 133.1, 132.7, 130.4, 130.2,
21.6, 119.4, 117.8, 1172.2, 114.0, 110.6, 103.6, 41.1, 40.3, 40.2, 15.4,
clear yet. Yield: 28 mg (0.028 mmol, 47%). H NMR (400 MHz,
CDCl ): δ 7.79 (s, 1H), 7.51 (d, J = 8.6 Hz, 1H), 7.44 (d, J = 8.6 Hz,
3
5.37 (broad singlet) ppm. MS (ESI, positive ions): m/z 237.1116
1H), 7.29 (d, J = 1.9 Hz, 1H), 7.20 (d, J = 1.9 Hz, 1H), 5.12−4.98
(m, 2H), 4.38 (q, J = 7.0 Hz, 4H), 1.74−1.63 (m, 24H) ppm.
+
(
calculated for [M + Na] 237.1104).
1
3
1
I
III
Synthesis of [L1-H ]Br (5). To a mixture of compound 4 (0.8 g,
C{ H} NMR (126 MHz, CDCl ): δ 174.4 (Au -CNHC), 172.5 (Ir -
3
2
2
3.77 mmol) and ethyl bromide (1.46 mL, 19.5 mmol) in a Schlenk
CNHC), 135.3, 135.2, 134.6, 122.3, 120.7, 119.9, 111.8, 108.5, 90.6
9
23
Organometallics 2021, 40, 915−926